Search

Marcia Stephens Noble

Examiner (ID: 19297, Phone: (571)272-5545 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
1089
Issued Applications
595
Pending Applications
110
Abandoned Applications
393

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14342845 [patent_doc_number] => 20190153395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => SYSTEMS AND METHODS FOR GROWTH OF INTESTINAL CELLS IN MICROFLUIDIC DEVICES [patent_app_type] => utility [patent_app_number] => 16/074747 [patent_app_country] => US [patent_app_date] => 2017-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074747 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/074747
Systems and methods for growth of intestinal cells in microfluidic devices Jan 31, 2017 Issued
Array ( [id] => 16663237 [patent_doc_number] => 10932454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => LDL receptor gene knockout, genetically-engineered hamster [patent_app_type] => utility [patent_app_number] => 16/074768 [patent_app_country] => US [patent_app_date] => 2017-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 6869 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074768 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/074768
LDL receptor gene knockout, genetically-engineered hamster Jan 31, 2017 Issued
Array ( [id] => 16681915 [patent_doc_number] => 10941382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-09 [patent_title] => Platelet production promoter and method of producing platelets using same [patent_app_type] => utility [patent_app_number] => 16/071598 [patent_app_country] => US [patent_app_date] => 2017-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 8082 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071598 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/071598
Platelet production promoter and method of producing platelets using same Jan 29, 2017 Issued
Array ( [id] => 14407461 [patent_doc_number] => 20190169574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => IN VITRO PRODUCTION OF PANCREATIC BETA CELLS [patent_app_type] => utility [patent_app_number] => 16/074870 [patent_app_country] => US [patent_app_date] => 2017-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074870 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/074870
IN VITRO PRODUCTION OF PANCREATIC BETA CELLS Jan 24, 2017 Abandoned
Array ( [id] => 11618407 [patent_doc_number] => 20170128594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'Humanized Viral Vectors and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 15/411489 [patent_app_country] => US [patent_app_date] => 2017-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15715 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411489 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/411489
Humanized viral vectors and methods of use thereof Jan 19, 2017 Issued
Array ( [id] => 11670303 [patent_doc_number] => 20170159023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'NOVEL LOW-MOLECULAR-COMPOUND FOR IMPROVING PRODUCTION, MAINTENANCE AND PROLIFERATION OF PLURIPOTENT STEM CELLS, COMPOSITION COMPRISING THE SAME, AND CULTURE METHOD' [patent_app_type] => utility [patent_app_number] => 15/411642 [patent_app_country] => US [patent_app_date] => 2017-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 19679 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411642 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/411642
Low-molecular-compound for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and culture method Jan 19, 2017 Issued
Array ( [id] => 13837533 [patent_doc_number] => 20190022251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-24 [patent_title] => Adeno-Associated Virus Virions for Treatment of Epilepsy [patent_app_type] => utility [patent_app_number] => 16/069370 [patent_app_country] => US [patent_app_date] => 2017-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069370 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/069370
Adeno-Associated Virus Virions for Treatment of Epilepsy Jan 12, 2017 Abandoned
Array ( [id] => 13774699 [patent_doc_number] => 20190000888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION [patent_app_type] => utility [patent_app_number] => 16/066014 [patent_app_country] => US [patent_app_date] => 2017-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13816 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066014 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/066014
Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction Jan 10, 2017 Issued
Array ( [id] => 11963825 [patent_doc_number] => 20170267978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/403653 [patent_app_country] => US [patent_app_date] => 2017-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 14511 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15403653 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/403653
INDUCED PLURIPOTENT STEM CELLS Jan 10, 2017 Abandoned
Array ( [id] => 14277831 [patent_doc_number] => 20190136200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => Cellular Reprogramming Utilizing mRNA [patent_app_type] => utility [patent_app_number] => 16/068469 [patent_app_country] => US [patent_app_date] => 2016-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068469 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/068469
Cellular Reprogramming Utilizing mRNA Dec 28, 2016 Abandoned
Array ( [id] => 11757500 [patent_doc_number] => 20170204368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'DERIVATION OF EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/390319 [patent_app_country] => US [patent_app_date] => 2016-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6095 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15390319 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/390319
DERIVATION OF EMBRYONIC STEM CELLS Dec 22, 2016 Abandoned
Array ( [id] => 15604279 [patent_doc_number] => 10583180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Method for treating adenosine deaminase severe combined imunodeficiency [patent_app_type] => utility [patent_app_number] => 15/383030 [patent_app_country] => US [patent_app_date] => 2016-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 83 [patent_no_of_words] => 32611 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383030 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/383030
Method for treating adenosine deaminase severe combined imunodeficiency Dec 18, 2016 Issued
Array ( [id] => 14665493 [patent_doc_number] => 10370637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-06 [patent_title] => Technology for sustaining pluripotency and improved growth of stem cells in culture [patent_app_type] => utility [patent_app_number] => 15/380811 [patent_app_country] => US [patent_app_date] => 2016-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4588 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380811 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/380811
Technology for sustaining pluripotency and improved growth of stem cells in culture Dec 14, 2016 Issued
Array ( [id] => 12541575 [patent_doc_number] => 10010058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Transgenic animal for production of antibodies having minimal CDRS [patent_app_type] => utility [patent_app_number] => 15/377940 [patent_app_country] => US [patent_app_date] => 2016-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 18633 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15377940 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/377940
Transgenic animal for production of antibodies having minimal CDRS Dec 12, 2016 Issued
Array ( [id] => 11514303 [patent_doc_number] => 20170081377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-23 [patent_title] => 'RTEF-1 VARIANTS AND THE USE THEREOF FOR INHIBITION OF ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 15/369583 [patent_app_country] => US [patent_app_date] => 2016-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22000 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15369583 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/369583
RTEF-1 variants and the use thereof for inhibition of angiogenesis Dec 4, 2016 Issued
Array ( [id] => 15383969 [patent_doc_number] => 10533157 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-01-14 [patent_title] => Recombinant NK cells expressing co-stimulatory molecules [patent_app_type] => utility [patent_app_number] => 15/366838 [patent_app_country] => US [patent_app_date] => 2016-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5882 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366838 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/366838
Recombinant NK cells expressing co-stimulatory molecules Nov 30, 2016 Issued
Array ( [id] => 13533809 [patent_doc_number] => 20180318447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY [patent_app_type] => utility [patent_app_number] => 15/772902 [patent_app_country] => US [patent_app_date] => 2016-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772902 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/772902
Compositions and methods for improving viral vector efficiency Nov 29, 2016 Issued
Array ( [id] => 11514566 [patent_doc_number] => 20170081640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-23 [patent_title] => 'COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/365823 [patent_app_country] => US [patent_app_date] => 2016-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29040 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365823 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/365823
Combined chemical and genetic approaches for generation of induced pluripotent stem cells Nov 29, 2016 Issued
Array ( [id] => 14039327 [patent_doc_number] => 20190075770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES [patent_app_type] => utility [patent_app_number] => 16/061769 [patent_app_country] => US [patent_app_date] => 2016-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061769 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/061769
GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES Nov 28, 2016 Abandoned
Array ( [id] => 11497800 [patent_doc_number] => 20170071985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/362261 [patent_app_country] => US [patent_app_date] => 2016-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17889 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15362261 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/362261
Extracellular matrix compositions for the treatment of cancer Nov 27, 2016 Issued
Menu